Calpains belong to a family of calcium-dependent thiol proteases. 12, 13 Fifteen gene products of the calpain family are reported in mammals. Among them, calpain-1 and calpain-2 are ubiquitously expressed, whereas other calpain family members have more limited tissue distribution. Both calpain-1 and calpain-2 are heterodimers. They consist of distinct large 80-kDa catalytic subunits encoded by capn1 and capn2, respectively, and a common small 28-kDa regulatory subunit encoded by capn4. The regulatory subunit is indispensable for calpain-1 and calpain-2 activities. These 2 calpain isoforms are regulated by the endogenous calpain inhibitor calpastatin. Our recent study demonstrated that overexpression of calpastatin reduced cardiac TNF-α expression and attenuated myocardial dysfunction in calpastatin transgenic mice (Tg-CAST) in response to lipopolysaccharides.
14 However, the underlying mechanisms by which calpain participates in the regulation of proinflammatory response remain to be defined. Moreover, tissue-specific gene deletion of calpain is generally considered to be more conclusive to clarify the contribution of cardiac calpain because the inhibition of systemic inflammation could not be excluded to confer cardiac protection in endotoxemia in Tg-CAST mice.
Although calpain-1 and calpain-2 have been considered mainly cytoplasmic enzymes, recent studies have found that they are also present in mitochondria. 15, 16 Mitochondrial calpains have been shown to play important roles in pathophysiological conditions. 16 However, it has never been shown whether calpains are altered in mitochondria and whether mitochondrial calpains contribute to proinflammatory response in septic hearts. Activation of mitochondrial calpains may be involved in mitochondrial dysfunction because several mitochondrial proteins have been suggested to be potential substrates of calpain, including, but not limited to, ATP5A1, 17 optic atrophy-1, 18 apoptosis-inducing factor, 19 and Na + /Ca 2+ exchanger-1. 20 Proteolysis of these mitochondrial proteins will compromise mitochondrial function and may lead to excessive reactive oxygen species (ROS) generation. Thus, calpain may regulate mitochondrial ROS production. Our recent study has demonstrated that lipopolysaccharides increase mitochondrial ROS and selectively blocking mitochondrial ROS inhibits TNF-α expression in cardiomyocytes. 21 Taken together, these studies raise an intriguing hypothesis that calpain activation may induce excessive mitochondrial ROS generation, leading to cardiac proinflammatory response and myocardial dysfunction in sepsis.
In this study, we used cardiomyocyte-specific capn4 knockout mice to investigate whether and how calpain activation disrupts ATP synthase and induces mitochondrial ROS generation in cultured cardiomyocytes and hearts during lipopolysaccharide stimulation.
Methods

Animals
This investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (National Institutes of Health Publication, 8th Edition, 2011). All experimental procedures were approved by the Animal Use Subcommittee at the University of Western Ontario, London, Canada. Breeding pairs of C57BL/6 mice were purchased from the Jackson Laboratory. Tg-CAST mice were generously provided by Dr Laurent Baud (the Institut National de la Santé et de la Recherche Médicale, Paris, France) through the European Mouse Mutant Archive. 22 Mice with cardiomyocyte-specific disruption of capn4 (capn4-ko) were generated as described previously. 23 All of the mice used in this study, including controls, were littermates of the same generation. Adult male mice (aged 2 months; 8-15 mice in each group) were injected with lipopolysaccharides (4 mg/kg IP) or saline as a control.
Statistical Analysis
All data were presented as mean±SD. Statistical comparisons between only 2 groups were done using an unpaired Student t test. For comparisons of >2 groups, 1-way ANOVA or 2-way ANOVA was performed as appropriate. Post hoc comparisons were performed using Newman-Keuls or Bonferroni comparison analysis in 1-way ANOVA or 2-way ANOVA, respectively. One-way repeated-measures ANOVA was performed for time course and dose response Figure 1 . Mitochondrial reactive oxygen species (ROS) generation, tumor necrosis factor-α (TNF-α) expression, and dysmyocardial function in capn4-ko mice and their wild-type (WT) littermates. Mice were injected with lipopolysaccharides (LPS) or saline (6-7 mice in each group). Four hours later, myocardial function was assessed (B) and the mRNA levels of TNF-α were measured (A). Mitochondrial ROS generation was determined after addition of pyruvate/malate (C) or succinate (D) using Amplex Red. Data are presented as mean±SD; n=4 to 7. *P<0.05 versus saline in WT and #P<0.05 versus LPS in WT. studies on mitochondrial superoxide flashes. A P value of <0.05 was considered statistically significant.
Expanded Methods are available in the Data Supplement.
Results
Deletion of capn4 Reduces Proinflammatory Response and Attenuates Myocardial Dysfunction in Endotoxemic Mice
To determine whether cardiomyocyte-specific deletion of capn4 provides beneficial effects in septic hearts, we injected capn4-ko and their wild-type mice with lipopolysaccharides or saline. As previously reported, 14 lipopolysaccharides induced TNF-α expression and decreased myocardial function in wild-type mice; however, deficiency of capn4 significantly attenuated TNF-α expression and myocardial dysfunction in endotoxemic capn4-ko mice (Figure 1A and 1B; Table I in the Data Supplement). Thus, cardiomyocyte-specific deletion of capn4 protects the heart against lipopolysaccharide-induced injury.
Genetic Inhibition of Calpain Prevents Mitochondrial Superoxide Generation in Hearts and Cultured Cardiomyocytes During Lipopolysaccharide Stimulation
Our recent study has shown that mitochondrial ROS contributes to lipopolysaccharide-induced proinflammatory response in cardiomyocytes. 24 In this study, we examined whether there is a link between calpain and mitochondrial ROS generation in endotoxemia. We determined ROS generation in isolated mitochondria of mouse hearts at 4 hours after lipopolysaccharide stimulation. Lipopolysaccharide treatment increased ROS generation in mitochondria using either pyruvate/malate or succinate as substrates ( Figure 1C and 1D ). Capn4 deletion significantly reduced ROS generation in mitochondria from lipopolysaccharide-stimulated capn4-ko mice ( Figure 1C and 1D). However, the antioxidant capacity slightly increased in response to lipopolysaccharides, and there was no difference between wild-type and capn4-ko mice (data not shown). These results suggest that calpain induces mitochondrial ROS generation in response to lipopolysaccharides, and the increase in mitochondrial ROS production is not because of the disruption of antioxidant defense system.
To confirm the role of calpain in mitochondrial ROS generation, we isolated and cultured cardiomyocytes from adult Tg-CAST and wild-type mice. Cardiomyocytes were infected with an adenoviral vector expressing mitochondria-targeted circularly permuted fluorescent protein (Ad-mt-cpYFP), 25 followed by incubation with lipopolysaccharides (0.1-5 μg/mL) or saline for ≤4 hours. Although cpYFP is also sensitive to the pH, our recent study showed that mt-cpYFP flash events reflect a burst in electron transport chain-dependent superoxide production that is coincident with a modest increase in matrix pH in cardiomyocytes. 26 Thus, we used cpYFP as a probe to analyze mitochondrial superoxide flashes in cardiomyocytes (Figure 2A ). Mitochondrial superoxide flashes in cardiomyocytes were inhibited by mitochondria-targeted superoxide dismutase mimetics ( Figure 2B ). Lipopolysaccharides increased mitochondrial superoxide generation in wild-type cardiomyocytes in a time-and dose-dependent manner ( Figure 2C and 2D). However, the increase in mitochondrial superoxide generation by lipopolysaccharides was abrogated in Tg-CAST cardiomyocytes ( Figure 2E ). These results demonstrate that calpain is important in mitochondrial superoxide generation in cardiomyocytes induced by lipopolysaccharide stimulation.
Lipopolysaccharides Induce Calpain-1 Accumulation in Mitochondria
To determine whether calpains were altered in mitochondria of lipopolysaccharide-treated mouse hearts, we prepared mitochondrial and cytosolic fractions from sham and lipopolysaccharide-stimulated mouse hearts. An intact set of mitochondrial proteins (voltage-dependent anion channel-1 [VDAC1], cytochrome c, cyclophilin D, complex Va, and ATP5A1) was detected in the mitochondrial fraction, whereas GAPDH and calreticulin appeared in cytosolic but not mitochondrial fraction, validating the purity and integrity of isolated mitochondria (Figure IA in the Data Supplement). The protein levels and activities of calpain-1 and calpain-2 were significantly elevated in mitochondria from lipopolysaccharide-treated hearts compared with saline-treated hearts ( Figure 3A-3D ). Lipopolysaccharides also increased calpain activities in cytosol of the heart (Figure IB in the Data Supplement). However, lipopolysaccharides did not change the protein levels of calpain-10, an isoform widely recognized as a mitochondrial calpain (data not shown). Because our recent study have implicated calpain-1 but not calpain-2 in lipopolysaccharide-induced TNF-α expression in cardiomyocytes, 14 we focused on investigating calpain-1 for the following studies.
To provide further evidence in support of calpain-1 accumulation in mitochondria, we determined calpain-1 and VDAC1 proteins in isolated mitochondria of lipopolysaccharide-treated mouse hearts by dual immunofluorescent confocal microscopy. Confocal microscopic analysis demonstrated that VDAC1 was detected in mitochondrial membrane (red), calpain-1 was present inside of mitochondria (green), and percentages of calpain-1-labeled mitochondria were much greater in lipopolysaccharide-treated hearts versus sham mouse hearts ( Figure 3E ). Immune-electron microscopy confirmed the localization of calpain-1 in mitochondria ( Figure 3F and  3G) . Consistently, there were much more calpain-1 signals in mitochondria of lipopolysaccharide-treated hearts than those of sham mouse hearts, whereas calpain-1 signals in cytosol remained comparable between sham and lipopolysaccharidetreated hearts ( Figure 3G ; Figure IIB in the Data Supplement). As a negative control for primary antibodies, no signal was observed when calpain-1 antibody was replaced by a negative IgG isotype ( Figure IIA ). These results demonstrate that lipopolysaccharides induce calpain-1 accumulation in mitochondria of the heart. However, inhibition of calpain activity prevented lipopolysaccharide-induced calpain-1 accumulation in mitochondria of mouse hearts ( Figure III in the Data Supplement), suggesting that calpain-1 may relocate to mitochondria after activation in response to lipopolysaccharides.
Targeted Overexpression of Calpastatin in Mitochondria Inhibits Superoxide Generation in Cardiomyocytes During Lipopolysaccharide Stimulation
To investigate the role of mitochondrial calpain, we infected cultured cardiomyocytes with adenoviral vector containing mitochondria-targeted calpastatin and then incubated them with lipopolysaccharides for 4 hours. Selective overexpression of calpastatin in mitochondria prevented mitochondrial superoxide flashes induced by lipopolysaccharides (Figure 4) . This result describes a crucial role of mitochondrial calpain in superoxide generation in cardiomyocytes during lipopolysaccharide stimulation. 
Upregulation of Calpain-1 Selectively in Mitochondria Induces Superoxide Generation and Proinflammatory Response in Cardiomyocytes
To provide direct evidence to support our hypothesis that the accumulation of calpain-1 in mitochondria contributes to superoxide generation and subsequent proinflammatory response, we transfected cardiomyocyte-like H9c2 cells with pCMV/ myc/mito-capn1, a plasmid expressing mitochondrial-targeted capn1. Twenty-four hours later, mitochondrial and cytosolic fractions were isolated from cardiomyocyte-like H9c2 cells. Overexpressed capn1 was confirmed as a myc-tagged protein in mitochondrial but not in cytosolic fractions ( Figure IV in the Data Supplement). Intriguingly, overexpression of capn1 restricted to mitochondria significantly increased mitochondrial superoxide generation and induced TNF-α expression in cardiomyocyte-like H9c2 cells, both of which were inhibited by mitochondria-targeted superoxide dismutase mimetics (Figure 5A and 5B). These results strongly implicate mitochondrial calpain-1 in ROS production and proinflammatory response.
ATP5A1 Is a Direct Target of Calpain-1 in Mitochondria in Response to Lipopolysaccharides
To explore the potential targets of calpain-1 in mitochondria, we pulled down the calpain-1 and its interacting proteins from isolated mitochondria of lipopolysaccharide-treated mouse hearts. Western blot analyses for a number of mitochondrial proteins (VDAC1, cytochrome c, cyclophidin D, Na + /Ca 2+ exchanger-1, ATP5A1, ATP synthase-β, and optic atrophy-1) revealed that only ATP5A1 was pulled down with calpain-1 ( Figure 6A1) . Likewise, calpain-1 was detected in immunecaptured ATP synthase complex ( Figure 6A2 ). These results demonstrate a physical interaction between calpain-1 and ATP5A1 in mitochondria. Furthermore, ATP5A1 is a direct substrate of calpain-1 because coincubation of active calpain-1 with recombinant ATP5A1 protein in vitro resulted in multiple cleavages of ATP5A1 ( Figure V in the Data Supplement).
Therefore, we reasoned that calpain-1 cleaved ATP5A1 and disrupted ATP synthase activity in mitochondria of lipopolysaccharide-treated mouse hearts. Accordingly, lipopolysaccharides reduced ATP synthase activity in mitochondria, which is consistent with previous reports. 27, 28 However, the reduction in ATP synthase activity was prevented by capn4 deletion ( Figure 6B ). In line with the reduction of ATP synthase activity, the protein levels of ATP5A1 were markedly decreased in mitochondria from lipopolysaccharide-treated wild-type hearts ( Figure 6C ) and restored in capn4-ko mice after lipopolysaccharide stimulation ( Figure 6D ). However, the mRNA levels of ATP5A1 remained comparable among those groups (data not shown). In cultured cardiomyocytes, selective overexpression of calpastatin in mitochondria by infection with adenoviral vector containing mitochondria-targeted calpastatin significantly attenuated lipopolysaccharideinduced reduction in ATP synthase activity ( Figure 4C ).
Overexpression of ATP5A1 Reduces Mitochondrial Superoxide Generation and TNF-α Expression and Attenuates Myocardial Dysfunction in Endotoxemic Mice
To investigate whether upregulation of ATP5A1 provides cardiac protection, we delivered adenoviral vector containing ATP5A1 into mice. Adenoviral vector containing green fluorescent protein served as a control. Forty-eight hours later, mice received lipopolysaccharides (4 mg/kg IP) or saline. Four hours later, delivery of adenoviral vector containing ATP51 significantly increased ATP5A1 protein in both sham and lipopolysaccharide-treated hearts ( Figure 7A ) and ATP synthase activity in lipopolysaccharide-treated hearts ( Figure 7B ), suggesting that ectopic expression of ATP5A1 integrates into the complex of ATP synthase. Upregulation of ATP5A1 reduced mitochondrial ROS generation ( Figure 7C ) and TNF-α expression in mouse hearts after lipopolysaccharide stimulation (Figure 7D ) and improved myocardial function in endotoxemic mice ( Figure 7E ; Table II in the Data Supplement).
In cultured cardiomyocytes, incubation with ATP synthase inhibitor oligomycin A increased mitochondrial superoxide flash generation (Figure VI in the Data Supplement). To provide direct evidence to support the role of ATP5A1, we infected cardiomyocytes with adenoviral vector containing ATP5A1 or adenoviral vector containing galactosidase as a control and then incubated them with lipopolysaccharides for 4 hours. Upregulation of ATP5A1 increased ATP synthase activity ( Figure 8A ) and reduced mitochondrial superoxide generation induced by lipopolysaccharides ( Figure 8B) . Similarly, infection with adenoviral vector containing ATP5A1 attenuated mitochondrial superoxide generation and TNF-α expression induced by mitochondrial-targeted calpain-1 in cardiomyocytes ( Figure 8C and 8D ).
Discussion
In this study, we demonstrate that lipopolysaccharide treatment increases calpain-1/calpain-2 in mitochondria and the accumulation of calpain in mitochondria correlates with mitochondrial ROS generation in the heart. Deletion of capn4 reduces mitochondrial ROS production in cardiomyocytes and the hearts in response to lipopolysaccharides. Selective upregulation of calpain-1 in mitochondria sufficiently induces superoxide generation and TNF-α expression in cardiomyocytes. Furthermore, calpain-1 in mitochondria disrupts ATP synthase through proteolysis of ATP5A1 in response to lipopolysaccharide stimulation. Upregulation of ATP5A1 inhibits mitochondrial superoxide generation in cardiomyocytes and attenuates TNF-α expression, leading to the improvement of myocardial function in endotoxemic mice. To our knowledge, this is the first study demonstrating a novel role of calpain-1 in disrupting ATP synthase and promoting mitochondrial superoxide generation in endotoxemic hearts.
In a rat model of endotoxemia, the role of calpain in myocardial dysfunction was suggested by using pharmacological inhibitors of calpain. 29 Further evidence came from our demonstration that overexpression of calpastatin attenuated myocardial dysfunction in Tg-CAST mice during lipopolysaccharide stimulation.
14 In this study using tissue-specific capn4 knockout mice, we show that deletion of capn4 decreases myocardial TNF-α expression, reduces mitochondrial ROS production, and attenuates myocardial dysfunction in endotoxemic mice. These findings verify the view that cardiac calpain plays a direct role in myocardial dysfunction in sepsis and may represent an important therapeutic target for sepsis.
Calpains have been shown to relocate to the membrane and nucleus in the heart under stress. 30, 31 They are also present in mitochondria. 16, 32, 33 A recent study has demonstrated that calpain-1 activity is increased in cardiac mitochondria during ischemia-reperfusion. 34 In this study, we demonstrate that lipopolysaccharides induce the accumulation of calpain-1 in mitochondria of the heart. Although it is currently unknown whether the accumulation of calpain-1 in mitochondria results from an increase in its translocation into mitochondria or a decrease in their degradation in mitochondria, our previous study showed that the protein levels of calpain-1 in wholeheart lysates were not altered after lipopolysaccharide stimulation, 14 suggesting that lipopolysaccharides may induce the translocation of calpain-1 into mitochondria. It is worthwhile to mention that immune-electron microscopic analysis shows no significant change in calpain-1 in the cytoplasm on lipopolysaccharide stimulation. Given that interfibrillar mitochondria constitute about 15% to 20% of cellular volume in cardiomyocytes, we think that a small portion of calpain-1 protein relocates to mitochondria, whereas the majority of calpain-1 remains in the cytoplasm. Thus, relocation of a small portion of calpain-1 may not significantly affect the protein levels of calpain-1 in the cytoplasm on lipopolysaccharide stimulation. Furthermore, the relocation of calpain-1 in mitochondria is dependent on its activation in response to lipopolysaccharides as inhibition of calpain prevents calpain-1 accumulation in mitochondria. Active calpain-1 mitochondrial translocation has been also shown in homocysteine-stimulated microvascular endothelial cells. 35 A recent study has identified a mitochondrial targeting sequence in the N-terminal region of capn1, which provides a molecular basis for calpain-1 mitochondrial translocation. 36 It is currently unknown what causes the translocation of active calpain-1 from cytosol to mitochondria in the setting of septic cardiomyopathy. A recent study demonstrated that calpain translocation to sarcolemmal was dependent on Ca 2+ entry through Na + /Ca 2+ exchanger in cardiomyocytes. 37 Given that mitochondrial Ca 2+ is altered in septic cardiomyocytes, 38 it is possible that mitochondrial Na + / Ca 2+ exchanger may facilitate the translocation of calpain-1 from cytosol to mitochondria in cardiomyocytes in response to lipopolysaccharide stimulation, which merits further investigation.
An important finding of this study is that calpain-1 accumulation in mitochondria mediates ROS generation in endotoxemic mouse hearts. Importantly, targeted overexpression of capn1 in mitochondria mimics the effect of lipopolysaccharide on mitochondrial superoxide generation in cardiomyocytes. Thus, this study provides a novel mechanism that mitochondrial superoxide is induced by calpain-1 in cardiomyocytes during lipopolysaccharide stimulation. Given the importance of mitochondrial ROS in cardiac pathophysiological processes, 39 further investigations are needed to clarify whether mitochondrial calpain-1 activation is a common mechanism for mitochondrial superoxide generation in other pathological conditions. Mitochondrial ROS induces the damage to mitochondria, which may promote more ROS production in mitochondria, forming the vicious circle, finally leading to mitochondrial dysfunction. 40 Mitochondrial ROS is also an important signaling mechanism in mediating gene expression. In this regard, we have recently demonstrated that mitochondrial ROS mediates TNF-α expression in cultured cardiomyocytes during lipopolysaccharide stimulation. 24 This study further demonstrates that selective overexpression of capn1 in mitochondria induces TNF-α expression in cardiomyocytes, which is inhibited by mitochondria-targeted superoxide dismutase mimetics, providing direct evidence in support of the view that mitochondrial calpain-1 mediates proinflammatory response through superoxide generation.
In an effort to explore the mechanisms by which calpain-1 induces superoxide generation in mitochondria, we demonstrate that ATP5A1 colocalizes with calpain-1 in lipopolysaccharide-treated mouse hearts. We further show that calpain-1 may cleave ATP5A1, substantiating the finding from a recent report that ATP5A1 is a potential substrate of calpain. 17 Disruption of ATP synthase inhibits ATP production, directly contributing to myocardial dysfunction. In septic hearts, ATP synthase activity and ATP production are decreased. 27, 28 Our observations are consistent with a model whereby calpain-1 accumulation in mitochondria compromises ATP synthase in lipopolysaccharide-treated mouse hearts. In fact, we show a significant reduction of ATP5A1 protein and of its activity in mitochondria from lipopolysaccharide-treated mouse hearts, which is prevented by capn4 deletion. On the other hand, disruption of ATP synthase within complex V results in excess electron backup in the individual electron transfer complexes, 40 in particular, complexes I and III, promoting mitochondrial superoxide generation. In support of this view, inhibition of ATP synthase activity directly increases mitochondrial superoxide generation in cardiomyocytes, and upregulation of ATP5A1 attenuates mitochondrial superoxide generation and TNF-α expression in cardiomyocytes induced by lipopolysaccharide and mitochondrial-targeted calpain-1. Furthermore, we show that upregulation of ATP5A1 increases ATP synthase activity, reduces mitochondrial ROS generation and TNF-α expression, and attenuates myocardial dysfunction in endotoxemic mice. Taken together, our observation argues that calpain-1 mediates mitochondrial superoxide generation, at least partly by disrupting ATP synthase, leading to lipopolysaccharide-induced proinflammatory response in the heart. It is worthwhile to mention that overexpression of ATP5A1 did not abrogate TNF-α expression in cardiomyocytes. This suggests that other targets of calpain-1 in mitochondria may exist in regulation of TNF-α expression, which merits further investigation. In fact, a recent study demonstrated that calpain also targets and cleaves apoptosis-inducing factor in mitochondria of the heart, 34 leading to ischemia/reperfusion injury. Thus, it is possible that calpain-mediated cleavage of apoptosisinducing factor may also contribute to septic cardiomyopathy, which needs further investigation for clarification.
In summary, this study has provided convincing evidence that calpain activation directly contributes to myocardial proinflammatory response to lipopolysaccharides by promoting mitochondrial calpain-1 translocation and ROS generation. ATP5A1 may represent an important target of calpain-1 in mitochondria, and its proteolysis disrupts ATP synthase, leading to mitochondrial superoxide generation in endotoxemia. Our study suggests that calpain and mitochondrial ROS may be potential therapeutic targets for myocardial dysfunction in sepsis.
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